Random peptide libraries (RPL) displayed on the surface of filamentous bacteriophages have been extensively used as a tool to map epitopes or to identify antigenic mimics (mimotpoes) of disease-specific monoclonal antibodies or polyclonal sera. These RPL are engineered by the insertion of degenerate oligonucleotides, encoding a specific number of random amino acids, in frame with a bacteriophage gene specifying a virion surface protein. The RPL are constructed by inserting 21 to 36 random nucleotides into the gene for an appropriate coat protein in a phage that is propagated in E. coli. Particularly, clear mimotopes have been obtained with monoclonal antibodies and with a few polyclonal antibodies against viruses. The choice and processing ...
Mapping polyclonal antibody responses to infectious diseases to identify individual epitopes has the...
Monoclonal antibody 6F5 (mAb 6F5), which recognizes the mycotoxin deoxynivalenol (DON) (vomitoxin), ...
The development of new and effective vaccines and immunodiagnostic reagents requires the characteris...
Random peptide libraries (RPL) displayed on the surface of filamentous bacteriophages have been exte...
Dermatophilosis commonly known as "lumpy wool" in sheep in Australia, is a skin disease of animals a...
Random peptide libraries (RFL) displayed on phage are being increasingly used to identify mimics of ...
AbstractThe use of polyclonal antibodies to screen random peptide phage display libraries often resu...
Abstract The aim of this study was to evaluate phage display technology for mapping Haemonchus cont...
A strategy to identify disease-specific epitopes from phage-displayed random peptide libraries using...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
We describe the use of random peptide sequences for the mapping of antigenic determinants. An oligon...
A monoclonal antibody (Mab 4.52) raised against Mycoplasma capricolum subsp. capripneumoniae (Mccp) ...
<div><p>A major hurdle in vaccine development is the difficulty in identifying relevant target epito...
Avibacterium paragallinarum is the causative agent of infectious coryza. The protective antigens of ...
Biopanning of phage-displayed random peptide libraries is a powerful technique for identifying pepti...
Mapping polyclonal antibody responses to infectious diseases to identify individual epitopes has the...
Monoclonal antibody 6F5 (mAb 6F5), which recognizes the mycotoxin deoxynivalenol (DON) (vomitoxin), ...
The development of new and effective vaccines and immunodiagnostic reagents requires the characteris...
Random peptide libraries (RPL) displayed on the surface of filamentous bacteriophages have been exte...
Dermatophilosis commonly known as "lumpy wool" in sheep in Australia, is a skin disease of animals a...
Random peptide libraries (RFL) displayed on phage are being increasingly used to identify mimics of ...
AbstractThe use of polyclonal antibodies to screen random peptide phage display libraries often resu...
Abstract The aim of this study was to evaluate phage display technology for mapping Haemonchus cont...
A strategy to identify disease-specific epitopes from phage-displayed random peptide libraries using...
A major hurdle in vaccine development is the difficulty in identifying relevant target epitopes and ...
We describe the use of random peptide sequences for the mapping of antigenic determinants. An oligon...
A monoclonal antibody (Mab 4.52) raised against Mycoplasma capricolum subsp. capripneumoniae (Mccp) ...
<div><p>A major hurdle in vaccine development is the difficulty in identifying relevant target epito...
Avibacterium paragallinarum is the causative agent of infectious coryza. The protective antigens of ...
Biopanning of phage-displayed random peptide libraries is a powerful technique for identifying pepti...
Mapping polyclonal antibody responses to infectious diseases to identify individual epitopes has the...
Monoclonal antibody 6F5 (mAb 6F5), which recognizes the mycotoxin deoxynivalenol (DON) (vomitoxin), ...
The development of new and effective vaccines and immunodiagnostic reagents requires the characteris...